Francois Erard
Orleans, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Chronic Pseudomonas aeruginosa Lung Infection Is IL-1R Independent, but Relies on MyD88 Signaling.
Journal: ImmunoHorizons
Published: November 10, 2020
Corrigendum: Blockade of IL-33R/ST2 Signaling Attenuates Toxoplasma gondii Ileitis Depending on IL-22 Expression.
Journal: Frontiers in immunology
Published: August 08, 2020
Blockade of IL-33R/ST2 Signaling Attenuates Toxoplasma gondii Ileitis Depending on IL-22 Expression.
Blockade of IL-33R/ST2 Signaling Attenuates Toxoplasma gondii Ileitis Depending on IL-22 Expression.
Journal: Frontiers in immunology
Published: December 11, 2018
The probiotic strain Escherichia coli Nissle 1917 prevents papain-induced respiratory barrier injury and severe allergic inflammation in mice.
Journal: Scientific reports
Published: September 12, 2017
Controlled Mycobacterium tuberculosis infection in mice under treatment with anti-IL-17A or IL-17F antibodies, in contrast to TNFα neutralization.
Journal: Scientific reports
Published: June 01, 2016
Innate myeloid cell TNFR1 mediates first line defence against primary Mycobacterium tuberculosis infection.
Journal: Scientific reports
Published: December 17, 2015
Protein kinase Cθ controls type 2 innate lymphoid cell and TH2 responses to house dust mite allergen.
Journal: The Journal of allergy and clinical immunology
Published: July 20, 2015
Control of Mycobacterial Infections in Mice Expressing Human Tumor Necrosis Factor (TNF) but Not Mouse TNF.
Journal: Infection and immunity
Published: June 05, 2015
Critical role of IL-33 receptor ST2 in experimental cerebral malaria development.
Journal: European journal of immunology
Published: September 18, 2014
Relative contribution of IL-1α, IL-1β and TNF to the host response to Mycobacterium tuberculosis and attenuated M. bovis BCG.
Journal: Immunity, inflammation and disease
Published: July 16, 2013
Airway structural cells regulate TLR5-mediated mucosal adjuvant activity.
Journal: Mucosal immunology
Published: April 12, 2013
Last Updated: 09/26/2026